Your browser doesn't support javascript.
loading
Low-dose intravenous tissue-type plasminogen activator for prosthetic valve thrombosis is better than standard dose streptokinase.
Biteker, Murat; Basaran, Özcan; Filiz Basaran, Nesrin; Sungur Biteker, Funda.
Affiliation
  • Biteker M; Mugla Sitki Koçman University, Faculty of Medicine, Department of Cardiology, Mugla, Turkey.
  • Basaran Ö; Mugla Sitki Koçman University, Faculty of Medicine, Department of Cardiology, Mugla, Turkey. Electronic address: basaran_ozcan@yahoo.com.
  • Filiz Basaran N; Mugla Sitki Koçman University, Faculty of Medicine, Department of Medical Pharmacology, Mugla, Turkey.
  • Sungur Biteker F; Mugla Sitki Koçman University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Mugla, Turkey.
Rev Port Cardiol ; 34(9): 569, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26320093
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptokinase / Tissue Plasminogen Activator Limits: Humans Language: En Journal: Rev Port Cardiol Journal subject: CARDIOLOGIA Year: 2015 Document type: Article Affiliation country: Turkey
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptokinase / Tissue Plasminogen Activator Limits: Humans Language: En Journal: Rev Port Cardiol Journal subject: CARDIOLOGIA Year: 2015 Document type: Article Affiliation country: Turkey